Memuat...

Advertisement

Evogene's Lavie Bio Inks Licensing Agreement For Bio-Fungicides With Corteva Agriscience

RTTNews | 773 hari yang lalu

Evogene's Lavie Bio Inks Licensing Agreement For Bio-Fungicides With Corteva Agriscience

(RTTNews) - Lavie Bio Ltd., a subsidiary of ag-biologicals company Evogene Ltd. (EVGN) announced on Monday a licensing agreement with ag innovation company Corteva Inc. (CTVA), that grants Corteva exclusive rights to further develop and commercialize the lead bio-fungicide product candidates targeting fruit rots and powdery mildew, which were discovered and developed by Lavie Bio.

The agreement comes after two years of independent field validation conducted by both companies.

The agreement is part of Lavie Bio's strategy to cooperate with the world's leading companies to allow the products it develops to reach farmers worldwide and Corteva, with its proven agbiological capabilities, can leverage Lavie Bio's product candidates toward commercial success.

This collaboration demonstrates both companies' commitment to providing farmers with environmentally friendly, sustainable tools with proven effectiveness.

Teg: EVGN CTVA

read more

Syngenta Crop, Lavie Bio Partner To Discover And Develop New Biological Insecticidal Solutions

Syngenta Crop, Lavie Bio Partner To Discover And Develop New Biological Insecticidal Solutions

Swiss agricultural innovation firm Syngenta Crop Protection and Israel's Lavie Bio Ltd., a leading ag-biologicals company and a subsidiary of Evogene Ltd. (EVGN), announced Tuesday an agreement for the discovery and development of new biological insecticidal solutions.

RTTNews | 555 hari yang lalu

Corteva Sees Q3 Results Below Estimates; Slashes FY23 Outlook

Corteva Sees Q3 Results Below Estimates; Slashes FY23 Outlook

Announcing preliminary net sales and earnings results for the third quarter on Friday, Corteva, Inc. (CTVA) now expects third-quarter loss from continuing operations of $0.45 per share on net sales of approximately $2.6 billion.

RTTNews | 671 hari yang lalu

Lavie Bio Appoints Guri Oron As CEO

Lavie Bio Appoints Guri Oron As CEO

Lavie Bio Ltd., a subsidiary of Evogene Ltd. (EVGN), announced Wednesday the appointment of Guri Oron as Chief Executive Officer of Lavie Bio, effective as of September 18, 2022.

RTTNews | 1079 hari yang lalu

Higher Open Called For China Stock Market

Higher Open Called For China Stock Market

The China stock market on Thursday snapped the two-day losing streak in which it had stumbled more than 80 points or 2.1 percent. The Shanghai Composite Index now sits just above the 3,840-point plateau and it's expected to see additional support on Friday.

RTTNews | 6 minit yang lalu

Rebound Anticipated For Taiwan Stock Market

Rebound Anticipated For Taiwan Stock Market

The Taiwan stock market on Thursday wrote a finish to the three-day winning streak in which it had jumped more than 750 points or 3.1 percent. The Taiwan Stock Exchange now rests just beneath the 24,230-point plateau although it figures to bounce higher again on Friday.

RTTNews | 36 minit yang lalu

Japan Retail Sales Add 0.3% In July

Japan Retail Sales Add 0.3% In July

The value of retail sales in Japan was up a seasonally adjusted 0.3 percent on month in July, the Ministry of Economy, Trade and Industry said on Friday - coming in at 13.335 trillion yen.

RTTNews | 1j 3min yang lalu

Singapore Stock Market May Add To Its Winnings On Friday

Singapore Stock Market May Add To Its Winnings On Friday

The Singapore stock market has finished higher in consecutive trading days, gathering more than 10 points or 0.25 percent in that span. The Straits Times Index now sits just above the 4,250-point plateau see additional support on Friday.

RTTNews | 1j 6min yang lalu

Japan Industrial Output Sinks 1.6% In July

Japan Industrial Output Sinks 1.6% In July

Industrial production in Japan was down a seasonally adjusted1.6 percent on month in July, the Ministry of Economy, Trade and Industry said on Friday.

RTTNews | 1j 8min yang lalu

Syarat | Privasi | Peta Laman | Site Map Calendar

&salin; 2025 Myfxbook Ltd. Hak Cipta Terpelihara.

PERINGATAN RISIKO TINGGI: Perdagangan pertukaran mata wang asing mempunyai risiko tinggi yang mungkin tidak sesuai untuk semua jenis pelabur. Leveraj menimbulkan risiko dan kerugian tambahan. Sebelum anda memutuskan untuk berdagang pertukaran mata wang asing, pertimbangkan dengan teliti objektif pelaburan, tahap pengalaman dan toleransi risiko anda. Anda berkemungkinan kehilangan sebahagian atau semua pelaburan awal anda. Jangan melaburkan wang yang anda tidak mampu untuk kehilangan. Didik diri anda tentang risiko yang berkaitan dengan perdagangan pertukaran asing, dan dapatkan nasihat daripada penasihat bebas kewangan atau cukai jika anda mempunyai sebarang pertanyaan mengenainya. Semua data dan maklumat yang disediakan adalah semata-mata untuk tujuan maklumat, dan bukan bertujuan untuk tujuan perdagangan atau nasihat. Prestasi masa lalu tidak semestinya menunjukkan hasil masa depan.